U.S. Hotel and Resort REITs Stock News

Recently, JPMorgan highlighted Canadian Solar as a short opportunity in the energy sector, citing increased input costs and regulatory headwinds, while Goldman Sachs reiterated a cautious outlook. This convergence of analyst concerns underscores the mounting challenges Canadian Solar faces in maintaining profitability and meeting compliance standards amid rising polysilicon prices and evolving U.S. regulations. We'll explore how mounting regulatory and margin pressures highlighted by...

If you are holding Hasbro stock or thinking about jumping in, you are probably asking yourself the big questions right now. Should you ride this comeback story for more upside, or is it time to lock in gains? There is plenty for investors to consider. While shares have dipped by 6.5% over the past week and are off 9.5% for the month, the picture looks much brighter from a broader perspective. Since the start of the year, Hasbro’s stock has surged 25.7%, and its three-year return sits at an...

In late September 2025, Dominion Energy completed fixed-income offerings of fixed-to-floating rate junior subordinated notes due in 2056, raising more than US$1.26 billion with features including callability, variable rates, and junior subordinated status. This funding move signals Dominion Energy's intent to maintain financial flexibility while advancing major projects and operations amid its evolving business focus. We'll examine how this substantial capital raise supports Dominion's focus...

On October 2, 2025, Compass Diversified announced that its Board of Directors declared quarterly cash distributions on all three of its preferred share series, with payments scheduled for October 30, 2025, to holders of record as of October 15, 2025. This announcement comes as investor attention intensifies around Compass Diversified’s subsidiary, Arnold Magnetic Technologies, following recent Chinese export controls on critical rare earth minerals. We'll assess how increased focus on...

Mineralys Therapeutics (MLYS) just completed enrollment in its Phase 2 EXPLORE-OSA trial, targeting lorundrostat for patients who have moderate to severe obstructive sleep apnea and hypertension. This marks a key step as the company prepares for upcoming results. See our latest analysis for Mineralys Therapeutics. Mineralys Therapeutics has seen impressive momentum recently, with a 244% year-to-date share price return and a 210.9% total shareholder return over the past year. This reflects...

Universal Display (OLED) recently caught attention after outperforming its industry peers with a Return on Equity of 14 percent and delivering steady net income growth over the past five years. See our latest analysis for Universal Display. Despite Universal Display’s strong business fundamentals, the past year has been tough for shareholders, with the total shareholder return down 32.8 percent even as some momentum returned in recent weeks. The stock’s multiyear track record, with a 52.8...

Kohl's (KSS) stock is treading water after several months of sharp swings, with the share price recently closing at $13.98. Investors are watching closely for signs that the retailer’s fundamentals could turn the tide in its favor. See our latest analysis for Kohl's. Kohl's has seen dramatic moves lately, with a 43.98% 90-day share price return fueling hopes of a rebound. However, momentum has faded in the short term, and the 1-year total shareholder return remains down 23%, reflecting...

Western Digital (WDC) has been drawing fresh attention after a flurry of analyst upgrades, earnings estimate revisions, and the company’s recent share buyback. Tightening supply conditions and improving margins in storage are fueling this momentum. See our latest analysis for Western Digital. Western Digital’s share price has seen a sharp run this year; after surging 18.2% over the past month, it is now up 86.6% year-to-date and has posted a standout 136.1% total shareholder return for the...

Earlier this month, Brookdale Senior Living reported substantial occupancy gains for September and the third quarter of 2025, alongside the appointment of Nikolas W. Stengle as the new Chief Executive Officer, effective October 6, 2025. These developments reflect both operational momentum, driven by improved move-in and move-out trends, and a leadership shift that may influence Brookdale’s direction within the senior living sector. To assess the impact of these operational improvements and...

In the past week, Eli Lilly announced strong long-term clinical trial results for its ulcerative colitis therapy Omvoh, showing sustained efficacy and a favorable safety profile over four years. Investors are also looking ahead to Eli Lilly’s quarterly earnings, which are expected to showcase robust sales for popular treatments Mounjaro and Zepbound. This combination of compelling clinical data and earnings optimism is reinforcing Eli Lilly’s reputation for innovation and product strength in...

Bio-Techne Corporation recently announced it has expanded its collaboration agreement with Oxford Nanopore Technologies, extending the partnership through 2032 and broadening its ability to develop and commercialize a wider range of targeted genetic testing kits for heritable disorder screening and diagnosis. An important insight from this announcement is that it builds on the successful 2025 launch of the AmplideX Nanopore Carrier Plus Kit, underscoring Bio-Techne's push deeper into the...

Rocket Lab, a leading aerospace company, has attracted attention after securing several major contracts with Japanese partners, including iQPS, Synspective, and the Japan Aerospace Exploration Agency (JAXA). These deals highlight the firm’s expanding role in global launch services and government space efforts. See our latest analysis for Rocket Lab. Rocket Lab’s string of major contract wins has generated intense buzz and helped fuel remarkable momentum in its shares. After a stellar run,...

Diginex (NasdaqCM:DGNX) has signed a strategic alliance with iNEED to deliver its ESG reporting platform to more than 1,000 rural banks across Indonesia. The agreement includes upfront payments and future revenue sharing. See our latest analysis for Diginex. The share price return over the past month has been nothing short of explosive, up 165.2%, with momentum accelerating after Diginex unveiled its transformative alliance in Indonesia. Although the stock saw heavy selling pressure today,...

Zions Bancorporation National Association (ZION) shares have dipped nearly 6% in the past day. Investors have taken note as the bank’s stock continues to trend lower for the month, prompting questions about underlying catalysts. See our latest analysis for Zions Bancorporation National Association. While Zions Bancorporation National Association’s share price has stumbled recently, with a 1-month share price return of -10.39%, the bigger picture is still in focus. Despite the short-term...

Evercore (EVR) has caught attention lately, with investors keeping an eye on its recent stock movement and solid financial results. Its steady revenue and net income growth provide an interesting backdrop for those following the financial sector. See our latest analysis for Evercore. Evercore has seen its share price slide 11.96% over the past month, giving back some of its earlier gains. Long-term investors have still enjoyed a 14.7% total shareholder return over the past year and over 250%...

Interactive Brokers Group (IBKR) has caught the attention of investors recently as the stock delivered strong 1-year and year-to-date returns, outpacing some peers. With shares up 84% over the past year, the company's performance deserves a closer look. See our latest analysis for Interactive Brokers Group. Momentum has been unmistakably strong for Interactive Brokers Group, with the stock’s 1-year total shareholder return soaring to nearly 84%. While the share price has taken a breather in...

Recent headlines put Nvidia (NVDA) in the spotlight as US-China trade tensions ramped up. The US Senate passed a bill targeting AI chip exports to China, while China responded with increased enforcement against US chipmakers, squeezing Nvidia’s access to a key market. See our latest analysis for NVIDIA. Nvidia’s stock has seen a sharp pullback lately, with a 4.9% drop in the past day as the headlines around trade and chip export curbs set a cautious tone. That said, momentum is cooling but...

Microsoft recently announced a landmark multi-year AI cloud infrastructure partnership with Nebius Group, involving an agreement valued at over US$17 billion and focused on delivering advanced GPU capacity from a new data center in New Jersey. This collaboration not only secures significant long-term revenue for Nebius Group but also highlights the shifting landscape as leading hyperscalers deepen ties with specialized AI infrastructure providers to meet soaring compute demand. We'll explore...

Wave Life Sciences (WVE) saw its shares climb in the latest session as excitement grows around new developments for its PRISM platform. Investors are watching upcoming clinical trial data that could shape the company’s revenue potential. See our latest analysis for Wave Life Sciences. Momentum in Wave Life Sciences’ RNA pipeline has caught investors’ attention, fueling a 9% share price gain over the past month. Despite this bump, the stock’s year-to-date share price return sits at -43%...

Stoke Therapeutics (STOK) has drawn fresh attention after unveiling new long-term clinical data for its lead therapy candidate, zorevunersen, at the 54th Child Neurology Society Annual Meeting. Results highlighted consistent cognitive, behavioral, and overall clinical gains for Dravet syndrome patients. See our latest analysis for Stoke Therapeutics. Stoke Therapeutics has enjoyed a powerful rally this year as optimism swelled around the company’s lead therapy and a series of strategic...

Recently, Nuvation Bio announced the enrollment of the first patient in TRUST-IV, a Phase 3 trial of IBTROZI™ (taletrectinib) for adjuvant treatment of resected ROS1-positive early-stage non-small cell lung cancer, with the study spanning the U.S., Canada, Europe, Japan, and China. This milestone follows collaboration with the U.S. FDA on the study design and marks an important step toward addressing a targeted oncology need. We'll explore how the global launch of this key Phase 3 trial...

Owens Corning presented at the CSCMP EDGE 2025 Conference on October 6, 2025, with Charlie Dahlke discussing the company's outbound and international logistics strategy. This participation highlights how Owens Corning is emphasizing its operational capabilities amid elevated investor interest ahead of its upcoming earnings report. We will explore how Owens Corning’s focus on logistics and operational efficiency may influence its current investment outlook. Find companies with promising cash...

Agilent Technologies (A) recently saw a wave of analyst upgrades, with UBS moving its rating to Buy as other firms also express optimism. Analysts are highlighting growth opportunities in life sciences as well as expanding success across key business lines. See our latest analysis for Agilent Technologies. Agilent’s share price has bounced back strongly, with a 10.9% gain over the past month and a 13.8% return over the last 90 days. Upbeat analyst coverage and major new product launches have...

Recent attention around Edison International (EIX) follows coverage underscoring its classification as a Buy, driven primarily by valuation metrics that compare favorably to industry peers. Investors are looking more closely at EIX because of optimism surrounding these factors. See our latest analysis for Edison International. While Edison International’s story has been grabbing attention for its value credentials, the share price tells a tale of volatility. It has slid 7.3% over the last...